Our newest #GBM CART paper now available Nature Cancer. No efficacy signal, but learned a lot about TME thanks to great work of @C_Alanio and others Institut Curie, Parker Institute for Cancer Immunotherapy, Penn Medicine, Penn Medicine - Abramson Cancer Center, Denis Migliorini, E. John Wherry, Beatty Lab nature.com/articles/s4301…

Excited to share our early phase 1 results for bivalent #CARTcells in recurrent #glioblastoma. Now online Nature Medicine. Awesome team effort! Penn Medicine Penn Medicine - Abramson Cancer Center Penn Neurosurgery DrORourke nature.com/articles/s4159…

Our full P1 trial paper now available Nature Medicine for treatment of recurrent #Glioblastoma completed at Penn Medicine MD Penn Medicine - Abramson Cancer Center with support from Kite, a Gilead Company #cureGBM We see anti tumor responses and have defined dose for ICV #CART cells